vs

Side-by-side financial comparison of Medalist Diversified REIT, Inc. (MDRR) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.

Taysha Gene Therapies, Inc. is the larger business by last-quarter revenue ($5.5M vs $2.8M, roughly 1.9× Medalist Diversified REIT, Inc.). Medalist Diversified REIT, Inc. runs the higher net margin — -18.8% vs -507.8%, a 489.0% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 11.8%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs 4.8%).

Medalist Diversified REIT, Inc. is a publicly traded real estate investment trust focused on owning, operating, and acquiring income-generating multi-family residential properties. Its portfolio is concentrated in high-growth US Southeast and Mid-Atlantic markets, targeting stable long-term returns for shareholders via rental income and property appreciation.

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.

MDRR vs TSHA — Head-to-Head

Bigger by revenue
TSHA
TSHA
1.9× larger
TSHA
$5.5M
$2.8M
MDRR
Growing faster (revenue YoY)
TSHA
TSHA
+159.5% gap
TSHA
171.3%
11.8%
MDRR
Higher net margin
MDRR
MDRR
489.0% more per $
MDRR
-18.8%
-507.8%
TSHA
Faster 2-yr revenue CAGR
TSHA
TSHA
Annualised
TSHA
26.8%
4.8%
MDRR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDRR
MDRR
TSHA
TSHA
Revenue
$2.8M
$5.5M
Net Profit
$-529.6K
$-27.9M
Gross Margin
Operating Margin
14.8%
-516.0%
Net Margin
-18.8%
-507.8%
Revenue YoY
11.8%
171.3%
Net Profit YoY
-88.4%
-48.3%
EPS (diluted)
$-0.49
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDRR
MDRR
TSHA
TSHA
Q4 25
$2.8M
$5.5M
Q3 25
$2.8M
$0
Q2 25
$2.5M
$2.0M
Q1 25
$2.3M
$2.3M
Q4 24
$2.5M
$2.0M
Q3 24
$2.3M
$1.8M
Q2 24
$2.3M
$1.1M
Q1 24
$2.6M
$3.4M
Net Profit
MDRR
MDRR
TSHA
TSHA
Q4 25
$-529.6K
$-27.9M
Q3 25
$-395.9K
$-32.7M
Q2 25
$-456.4K
$-26.9M
Q1 25
$-1.0M
$-21.5M
Q4 24
$-281.2K
$-18.8M
Q3 24
$-527.0K
$-25.5M
Q2 24
$-521.7K
$-20.9M
Q1 24
$1.4M
$-24.1M
Operating Margin
MDRR
MDRR
TSHA
TSHA
Q4 25
14.8%
-516.0%
Q3 25
15.8%
Q2 25
9.8%
-1347.1%
Q1 25
-23.8%
-930.5%
Q4 24
17.7%
-985.8%
Q3 24
13.0%
-1448.4%
Q2 24
9.4%
-1915.4%
Q1 24
-713.3%
Net Margin
MDRR
MDRR
TSHA
TSHA
Q4 25
-18.8%
-507.8%
Q3 25
-14.2%
Q2 25
-18.5%
-1353.6%
Q1 25
-43.4%
-935.2%
Q4 24
-11.1%
-929.0%
Q3 24
-22.6%
-1427.5%
Q2 24
-22.7%
-1882.0%
Q1 24
52.8%
-705.4%
EPS (diluted)
MDRR
MDRR
TSHA
TSHA
Q4 25
$-0.49
$-0.08
Q3 25
$-0.33
$-0.09
Q2 25
$-0.34
$-0.09
Q1 25
$-0.74
$-0.08
Q4 24
$-0.24
$-0.07
Q3 24
$-0.47
$-0.10
Q2 24
$-0.47
$-0.09
Q1 24
$1.21
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDRR
MDRR
TSHA
TSHA
Cash + ST InvestmentsLiquidity on hand
$2.6M
$319.8M
Total DebtLower is stronger
$51.4M
Stockholders' EquityBook value
$9.4M
$246.9M
Total Assets
$77.7M
$343.3M
Debt / EquityLower = less leverage
5.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDRR
MDRR
TSHA
TSHA
Q4 25
$2.6M
$319.8M
Q3 25
$1.9M
$297.3M
Q2 25
$2.0M
$312.8M
Q1 25
$2.7M
$116.6M
Q4 24
$4.8M
$139.0M
Q3 24
$3.1M
$157.7M
Q2 24
$3.8M
$172.7M
Q1 24
$3.6M
$124.0M
Total Debt
MDRR
MDRR
TSHA
TSHA
Q4 25
$51.4M
Q3 25
$63.6M
Q2 25
$49.6M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MDRR
MDRR
TSHA
TSHA
Q4 25
$9.4M
$246.9M
Q3 25
$10.4M
$219.0M
Q2 25
$13.4M
$248.7M
Q1 25
$14.0M
$55.1M
Q4 24
$15.0M
$71.5M
Q3 24
$12.6M
$88.8M
Q2 24
$13.2M
$108.9M
Q1 24
$13.7M
$53.8M
Total Assets
MDRR
MDRR
TSHA
TSHA
Q4 25
$77.7M
$343.3M
Q3 25
$92.1M
$316.6M
Q2 25
$77.7M
$333.3M
Q1 25
$78.2M
$138.4M
Q4 24
$75.1M
$160.4M
Q3 24
$74.6M
$180.2M
Q2 24
$75.2M
$200.4M
Q1 24
$76.0M
$153.0M
Debt / Equity
MDRR
MDRR
TSHA
TSHA
Q4 25
5.45×
Q3 25
6.13×
Q2 25
3.70×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDRR
MDRR
TSHA
TSHA
Operating Cash FlowLast quarter
$1.5M
$-26.7M
Free Cash FlowOCF − Capex
$77.0K
FCF MarginFCF / Revenue
2.7%
Capex IntensityCapex / Revenue
51.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDRR
MDRR
TSHA
TSHA
Q4 25
$1.5M
$-26.7M
Q3 25
$1.6M
$-24.2M
Q2 25
$244.1K
$-20.2M
Q1 25
$460.0K
$-22.0M
Q4 24
$1.8M
$-18.3M
Q3 24
$139.9K
$-21.6M
Q2 24
$778.6K
$-21.5M
Q1 24
$492.4K
$-19.8M
Free Cash Flow
MDRR
MDRR
TSHA
TSHA
Q4 25
$77.0K
Q3 25
$1000.0K
$-24.3M
Q2 25
$-181.5K
Q1 25
$322.4K
Q4 24
$893.7K
$-18.3M
Q3 24
$-164.7K
$-21.6M
Q2 24
$645.6K
$-21.7M
Q1 24
$265.8K
$-19.9M
FCF Margin
MDRR
MDRR
TSHA
TSHA
Q4 25
2.7%
Q3 25
35.9%
Q2 25
-7.4%
Q1 25
13.9%
Q4 24
35.4%
-905.5%
Q3 24
-7.0%
-1210.9%
Q2 24
28.1%
-1951.9%
Q1 24
10.3%
-584.5%
Capex Intensity
MDRR
MDRR
TSHA
TSHA
Q4 25
51.5%
Q3 25
20.4%
Q2 25
17.3%
Q1 25
5.9%
Q4 24
35.7%
0.1%
Q3 24
13.0%
2.0%
Q2 24
5.8%
18.1%
Q1 24
8.8%
4.1%
Cash Conversion
MDRR
MDRR
TSHA
TSHA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDRR
MDRR

Retail Center Properties$1.6M58%
Other$1.2M42%

TSHA
TSHA

Segment breakdown not available.

Related Comparisons